| 55096-26-9 Basic information More.. |
Product Name: | Nalmefene | Synonyms: | [5ALPHA]-17-[CYCLOPROPYLMETHYL]-4,5-EPOXY-6-METHYLENEMORPHINAN-3,14-DIOL;17-(cyclopropylmethyl)-4,5alpha-epoxy-6-methylenemorphinan-3,14-diol;NALMEFENE;(5alpha)-17-(cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinon-3,14-diol;6-desoxy-6-methylenenaltrexone;nalmetrene;(5α)-17-(cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinan-3,14-diol;6-Deoxo-6-methylenenaltrexone | CAS: | 55096-26-9 | MF: | C21H25NO3 | MW: | 339.44 | EINECS: | | Mol File: | 55096-26-9.mol | |
Use
Nalmefene (Revex) is a pure opioid antagonist that is the6-methylene analog of naltrexone. It is available as a solutionfor IV, IM, or subcutaneous (SC) administration toreverse the effects of opioids after general anesthesia andin the treatment of overdose. It is longer acting than naloxonebut otherwise has a similar pharmacodynamic andmetabolic (3-glucuronidation) profile. Nalmefene hashigher oral bioavailability (approximately 40%) thannaloxone or naltrexone and is currently being investigatedas an oral treatment for pathological gambling and alcoholabuse.
|
55096-26-9
Recommend Suppliers |
|